BridgeMD
Tests treatment safety and results for Carpal Tunnel Syndrome
Official title Ultrasound-Guided Curved Needle Thread Carpal Tunnel Release: Efficacy and Safety of a Single-Center, Single-Arm Clinical Trial
ClinicalTrials.gov ID: NCT06440070
What this study is testing
- What it's testing
- Carpal tunnel syndrome is a set of symptoms and signs caused by compression of the median nerve within the carpal tunnel. The prevalence in the general population is about 3.72%, with a rising trend, making it the most common peripheral nerve entrapment syndrome.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 70
You may be able to join if
- Aged between 40 and 70 years;
- Exhibiting symptoms consistent with carpal tunnel syndrome (e.g., finger numbness, tingling, weakness, or pain; symptoms aggravated by repetitive or...
- Meeting the diagnostic criteria for typical or possible carpal tunnel syndrome based on the Katz hand diagram for carpal tunnel syndrome [14];
- Ultrasound indicating thickening of the transverse carpal ligament, compressing the median nerve;
- Ineffective conservative treatment (e.g., immobilization, oral NSAIDs, local corticosteroid injections) for more than 3 months;
You likely can't join if
- Ultrasound examination reveals bifurcation of the median nerve or the presence of a persistent median artery at the carpal tunnel entrance, or...
- Systemic infection or local infection at the surgical site;
- Severe coagulation disorders;
- Previous carpal tunnel syndrome surgery on the affected side for this operation;
- Patients with uncontrolled epilepsy, cervical radiculopathy, or diabetic peripheral neuropathy;
- Allergy to local anesthetics;
See the full eligibility criteria
- Aged between 40 and 70 years;
- Exhibiting symptoms consistent with carpal tunnel syndrome (e.g., finger numbness, tingling, weakness, or pain; symptoms aggravated by repetitive or sustained gripping; symptoms worsening at night) and signs (sensory...
- Meeting the diagnostic criteria for typical or possible carpal tunnel syndrome based on the Katz hand diagram for carpal tunnel syndrome [14];
- Ultrasound indicating thickening of the transverse carpal ligament, compressing the median nerve;
- Ineffective conservative treatment (e.g., immobilization, oral NSAIDs, local corticosteroid injections) for more than 3 months;
- Signing the informed consent form.
- Ultrasound examination reveals bifurcation of the median nerve or the presence of a persistent median artery at the carpal tunnel entrance, or compression at the carpal tunnel caused by cysts, tumors, or fracture...
- Systemic infection or local infection at the surgical site;
- Severe coagulation disorders;
- Previous carpal tunnel syndrome surgery on the affected side for this operation;
- Patients with uncontrolled epilepsy, cervical radiculopathy, or diabetic peripheral neuropathy;
- Allergy to local anesthetics;
- Inability to complete the questionnaire due to language or cognitive impairments;
- Patients with severe heart, lung, liver, or brain diseases;
- Patients with mental illnesses;
- Participation in other clinical trials within the last three months;
- Pregnant or breastfeeding women.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.